image: “Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especially with rare blood and bone marrow cancers such as MDS,” said Dr. Mikkael Sekeres, chief of Hematology at Sylvester Comprehensive Cancer Center. view more Credit: Photo by Clutch Content Partners MIAMI, FLORIDA (EMBARGOED UNTIL AUG. 8, 2023 AT […]
“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especially with rare blood and bone marrow cancers such as MDS,” said Dr. Mikkael Sekeres, chief of Hematology at Sylvester Comprehensive Cancer Center. Credit: Clutch Content Partners Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are […]
People diagnosed with rare blood and bone marrow cancers like MDS were found to be receiving inappropriate treatments “almost 10% of the time.” Recent research from the Sylvester team and their partners sheds light on the challenges of diagnosing blood diseases, emphasizing the essential collaboration between doctors and pathologists. Diagnosing myelodysplastic syndromes/neoplasms (MDS) – a […]
Introduction Genitourinary syndrome of menopause (GSM) refers to the multitude of genital, urinary and sexual symptoms developing in women as a consequence of menopause and age-driven anatomical and functional modifications in urogenital tissues.1 Vaginal dryness, dyspareunia, burning, itching and discomfort are the typical clinical manifestations of vulvovaginal atrophy (VVA), also known as atrophic vaginitis, the […]
Abstract The genetic mutations that contribute to the transformation of healthy cells into cancerous cells have been the subject of extensive research. The molecular aberrations that lead to cancer development are often characterised by gain-of-function or loss-of-function mutations in a variety of oncogenes and tumour suppressor genes. In this study, we investigate the genomic sequences […]
New York, USA, Aug. 07, 2023 (GLOBE NEWSWIRE) — Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies – Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli Lilly The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of […]
